Clinical Trial Update: Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Monoclonal Antibody Therapy Rencarex® in patients who had surgery for non-metastatic kidney cancer has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Non-metastatic Kidney Cancer

Drugs mentioned

• Rencarex®

Snippet

Sponsor: Heidelberg Pharma AG | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-09-12